Alerts
PDF
Other content recommended for you
- Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis
- Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo
- Effects of vaccines in protecting against Ebola virus disease: protocol for a systematic review
- Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries
- COVID-19 vaccine trials with children: ethics pointers
- Adenovirus and RNA-based COVID-19 vaccines’ perceptions and acceptance among healthcare workers in Saudi Arabia: a national survey
- Review of COVID-19 vaccine subtypes, efficacy and geographical distributions
- Ebola: a game changer for vaccines, or a scare that will soon be forgotten?
- Incentivising wealthy nations to participate in the COVID-19 Vaccine Global Access Facility (COVAX): a game theory perspective
- Forty-two years of responding to Ebola virus outbreaks in Sub-Saharan Africa: a review